1-27 of about 27 matches for site:www.researchsquare.com outcomes
https://www.researchsquare.com/article/rs-1749502/v1
Submit a Preprint Cite Share Download PDF Article Outcomes of SARS-CoV-2 Reinfection Ziyad Al-AlyOutcomes of SARS-CoV-2 Reinfection | Research Square Browse
https://www.researchsquare.com/article/rs-1749502/v1
in each Health and Human Services region. Outcomes Outcomes were pre-specified on the basis ofSubmit a Preprint Cite Share Download PDF Article Outcomes of SARS-CoV-2 Reinfection Ziyad Al-AlyOutcomes of SARS-CoV-2 Reinfection | Research Square Browse
Impact of coronavirus disease 2019 (COVID-19) on the perioperative outcomes of maternal and neonatal
https://www.researchsquare.com/article/rs-4250438/v1
coronavirus disease 2019 (COVID-19) on the perioperative outcomes of maternal and neonatal prognosis: A
https://www.researchsquare.com/article/rs-4300936/v1
Disease profile and main outcomes of COVID 19 in a population
Global burden of ischemic stroke attributable to high body-mass index in 204 countries and territori
https://www.researchsquare.com/article/rs-4385787/v1
a variety of cardiovascular and cerebrovascular outcomes, although no studies were covered on deaths and DALY
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID sympto
https://www.researchsquare.com/article/rs-1756189/v2
led to lung inflammation and worst outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. Transplanted mice
The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinica
https://www.researchsquare.com/article/rs-2050004/v1
based on data that shows its association with long-term outcomes [ 25 ]. With a direct trial in humans
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID sympto
https://www.researchsquare.com/article/rs-1756189/v2
led to lung inflammation and worst outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. Transplanted mice
The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinica
https://www.researchsquare.com/article/rs-2050004/v1
based on data that shows its association with long-term outcomes [ 25 ]. With a direct trial in humans
https://www.researchsquare.com/article/rs-1003006/v1
were not randomised appropriately, which could bias the outcomes. Secondly, a study by Okumus et al from
https://www.researchsquare.com/browse
mechanisms for susceptibility to adverse reproductive outcomes Michal Elovitz, Lauren Anton, Ana Cristancho, Briana Ferguson, Andrea Joseph
https://www.researchsquare.com/coronavirus
31 09:35:32 Disease profile and main outcomes of COVID 19 in a population
https://www.researchsquare.com/blog
on the strength or direction of their outcomes rather than the soundness of the
Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearanc
https://www.researchsquare.com/article/rs-4311124/v1
during the outbreak due to inventory limitations. Outcomes Outcomes of the cohort study were (1) 28evaluate the clinical effectiveness and virological outcomes following the use of molnupiravir, azvudine
https://www.researchsquare.com/article/rs-5284562/v1
of the effectiveness and long-term outcomes of environmental education initiatives in Taiwan
https://www.researchsquare.com/legal/editorial
to impact the reporting of research outcomes in the submitted work. Research Square therefore
https://www.researchsquare.com/blog/how-to-avoid-bias-in-research
to underestimate outcomes. Similarly, investigators may over or underestimate outcomes if they know participants’ group status. Blinding helps ensure thatthe methods that will be used and outcomes that will be measured. Protocols help reduce the risk
RRM2: a crosstalk gene for COVID-19 and intervertebral disc degeneration revealed by integrated WGCN
https://www.researchsquare.com/article/rs-4244782/v1
the automatic construction of networks .The outcomes were examined by using the topological overlap matrix
Trends and patterns of ICU referrals in the Kingdom of Saudi Arabia during the COVID- 19 pandemic: R
https://www.researchsquare.com/article/rs-4295214/v1
of ICU capacity has significant negative impacts on patient outcomes as well as on the well-being of
Covid-19 Vaccination Uptake Among Remote Communities in Malaysia: A Cross-sectional Study | Research
https://www.researchsquare.com/article/rs-4312480/v1
infection and a propensity for severe outcomes, such as acute respiratory distress syndrome (ARDS) and cytokine
https://www.researchsquare.com/research-quality-evaluation
goal is to accelerate peer review, thus improving outcomes for authors, reviewers, and journal editors
Real-World Experience of Treatment With Thrombopoietin Receptor Agonists in Anti-thymocyte Globulin-
https://www.researchsquare.com/article/rs-953779/v1
n = 2; invasive aspergillus infection, n = 1. 3.2 Clinical outcomes Initially, all patients received eltrombopag when the TPO
The digital witness: Exploring gestural misinformation in tele-forensic interviews with 5-8-year-old
https://www.researchsquare.com/article/rs-4311500/v1
the tele-FI condition. Age did not affect interview outcomes. This study provides further evidence for tele-FI
Real-World Experience of Treatment With Thrombopoietin Receptor Agonists in Anti-thymocyte Globulin-
https://www.researchsquare.com/article/rs-953779/v1
n = 2; invasive aspergillus infection, n = 1. 3.2 Clinical outcomes Initially, all patients received eltrombopag when the TPO
QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SA
https://www.researchsquare.com/article/rs-4308184/v1
with a milder disease course, while severe clinical outcomes have been associated with the absence of
https://www.researchsquare.com/article/rs-3552451/v1
which results in five types of outcomes of pairwise interactions (a mutually neutral
Assessment of the Efficacy and Safety of Baricitinib Treatment in COVID-19 Patients: a real-world st
https://www.researchsquare.com/article/rs-4418170/v1
like tocilizumab have shown potential to enhance clinical outcomes in critical cases of COVID-19